Overview

• Rajasthan froze 22 batches of a government-supplied dextromethorphan syrup, halted supplies from Kayson Pharma, and told hospitals not to dispense remaining stock after two child deaths and multiple illnesses.
• Chhindwara district in Madhya Pradesh reported six pediatric deaths with acute kidney injury; authorities banned Coldrif and Nextro-DS and deployed NCDC and ICMR teams to collect drug, blood, water and entomological samples.
• Officials say final lab reports are pending, though some reports cite diethylene glycol detected in kidney biopsies in MP, while the state’s deputy chief minister said preliminary tests found no contamination.
• Rajasthan’s drug inspector collected statutory samples in Sikar, Jhunjhunu and Bharatpur, with test results expected within days, and over 1.33 lakh bottles distributed since July now under scrutiny.
• A community health centre doctor in Bharatpur who drank the syrup to reassure parents later fell unconscious, underscoring clinical concerns as regulators examine procurement and quality-control lapses.